Compare Stocks: AORT, ITGR, LIVN, and PLSE

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$22.25 -0.3%	$25.94	$19.16 ▼ $48.25	$1.08B	1.23	611,417 shs	559,446 shs
ITGR Integer	$126.47 +0.0%	$123.57	$62.00 ▼ $126.79	$4.30B	0.58	728,163 shs	471,806 shs
LIVN LivaNova	$75.07	$79.30	$48.82 ▼ $85.76	$4.14B	0.87	644,214 shs	528,515 shs
PLSE Pulse Biosciences	$47.90	$47.35	$12.56 ▼ $58.90	$3.39B	1.57	623,351 shs	519,133 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	0.00%	-1.97%	-13.05%	-10.08%	-45.85%
ITGR Integer	0.00%	+0.14%	+0.05%	+35.46%	+20.20%
LIVN LivaNova	0.00%	-2.04%	-8.36%	-10.66%	+40.66%
PLSE Pulse Biosciences	0.00%	-7.22%	-10.03%	+64.55%	+148.32%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$22.25 -0.3%	$25.94	$19.16 ▼ $48.25	$1.08B	1.23	611,417 shs	559,446 shs
ITGR Integer	$126.47 +0.0%	$123.57	$62.00 ▼ $126.79	$4.30B	0.58	728,163 shs	471,806 shs
LIVN LivaNova	$75.07	$79.30	$48.82 ▼ $85.76	$4.14B	0.87	644,214 shs	528,515 shs
PLSE Pulse Biosciences	$47.90	$47.35	$12.56 ▼ $58.90	$3.39B	1.57	623,351 shs	519,133 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	0.00%	-1.97%	-13.05%	-10.08%	-45.85%
ITGR Integer	0.00%	+0.14%	+0.05%	+35.46%	+20.20%
LIVN LivaNova	0.00%	-2.04%	-8.36%	-10.66%	+40.66%
PLSE Pulse Biosciences	0.00%	-7.22%	-10.03%	+64.55%	+148.32%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AORT Artivion	2.71	Moderate Buy	$44.83	101.50% Upside
ITGR Integer	2.07	Hold	$109.86	-13.13% Downside
LIVN LivaNova	2.55	Moderate Buy	$84.13	12.06% Upside
PLSE Pulse Biosciences	2.86	Moderate Buy	$50.20	4.80% Upside

Current Analyst Ratings Breakdown

Latest AORT, ITGR, LIVN, and PLSE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/23/2026	PLSE Pulse Biosciences	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$70.00
9/23/2026	PLSE Pulse Biosciences	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$70.00
9/14/2026	ITGR Integer	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
9/9/2026	PLSE Pulse Biosciences	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
9/2/2026	LIVN LivaNova	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$87.00 ➝ $90.00
8/19/2026	LIVN LivaNova	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/18/2026	LIVN LivaNova	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/18/2026	AORT Artivion	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$39.00 ➝ $40.00
8/17/2026	PLSE Pulse Biosciences	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$58.00
8/13/2026	ITGR Integer	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/11/2026	AORT Artivion	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D-)

(Data available from 10/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AORT Artivion	$441.33M	2.46	$1.10 per share	20.25	$9.46 per share	2.35
ITGR Integer	$1.85B	2.32	$10.37 per share	12.20	$49.85 per share	2.54
LIVN LivaNova	$1.39B	2.98	$4.84 per share	15.52	$21.98 per share	3.42
PLSE Pulse Biosciences	$350K	9,689.49	N/A	N/A	$1.19 per share	40.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AORT Artivion	$9.77M	-$0.07	N/A	28.90	N/A	-0.67%	6.07%	2.93%	11/5/2026 (Estimated)
ITGR Integer	$102.81M	$3.66	34.55	18.85	2.40	6.97%	12.79%	6.48%	10/22/2026 (Estimated)
LIVN LivaNova	-$242.47M	$3.38	22.21	18.05	N/A	12.82%	16.35%	7.76%	11/4/2026 (Estimated)
PLSE Pulse Biosciences	-$72.78M	-$1.18	N/A	N/A	N/A	-6,755.78%	-94.42%	-79.96%	11/4/2026 (Estimated)

Latest AORT, ITGR, LIVN, and PLSE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/22/2026	Q3 2026	ITGR Integer	$1.68	N/A	N/A	N/A	$456.91 million	N/A
8/6/2026	Q2 2026	AORT Artivion	$0.0025	$0.13	+$0.1275	-$0.28	$119.99 million	$125.76 million
8/6/2026	Q2 2026	LIVN LivaNova	$1.09	$1.26	+$0.17	$1.93	$380.50 million	$390.59 million
8/6/2026	Q2 2026	PLSE Pulse Biosciences	-$0.2933	-$0.36	-$0.0667	-$0.36	$0.53 million	$0.43 million
8/3/2026	Q2 2026	ITGR Integer	$1.38	$1.60	+$0.22	$0.69	$451.07 million	$464.11 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AORT Artivion	N/A	N/A	N/A	N/A	N/A
ITGR Integer	N/A	N/A	N/A	N/A	N/A
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AORT Artivion	0.82	3.47	2.51
ITGR Integer	0.75	3.73	2.41
LIVN LivaNova	0.22	1.45	1.21
PLSE Pulse Biosciences	N/A	9.63	9.61

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AORT Artivion	86.37%
ITGR Integer	99.29%
LIVN LivaNova	97.64%
PLSE Pulse Biosciences	76.95%

Insider Ownership

Company	Insider Ownership
AORT Artivion	6.30%
ITGR Integer	1.10%
LIVN LivaNova	0.35%
PLSE Pulse Biosciences	74.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AORT Artivion	1,800	48.76 million	45.68 million	Optionable
ITGR Integer	11,000	34.00 million	33.62 million	Optionable
LIVN LivaNova	3,300	55.09 million	54.90 million	Optionable
PLSE Pulse Biosciences	116	70.80 million	18.41 million	Optionable

AORT, ITGR, LIVN, and PLSE Headlines

Recent News About These Companies

Pulse Biosciences stock faces Oppenheimer meeting after 3.87 percent fall

October 4 at 11:48 PM | ad-hoc-news.deA

Pulse Biosciences (PLSE) Stock Fair Value Rises After Analysts Back NsPFA Data

October 3 at 7:10 PM | finance.yahoo.com

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.1% - Here's Why

September 29, 2026 | marketbeat.com

Pulse Biosciences: Promising Technology, But Hard To Justify Its Valuation

September 27, 2026 | seekingalpha.com

Pulse Biosciences (NASDAQ:PLSE) Research Coverage Started at BTIG Research

September 26, 2026 | americanbankingnews.com

Pulse Biosciences stock reports 100 patient trial milestone

September 24, 2026 | ad-hoc-news.deA

Pulse Biosciences (NASDAQ:PLSE) Upgraded to Strong-Buy at BTIG Research

September 24, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 3.3% - What's Next?

September 23, 2026 | marketbeat.com

1,446,611 Shares in Pulse Biosciences, Inc $PLSE Purchased by Bank of America Corp DE

September 22, 2026 | marketbeat.com

Pulse Biosciences Completes Enrollment in 100-Patient Thyroid Nodule Study

September 16, 2026 | finance.yahoo.com

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down - Should You Sell?

September 16, 2026 | marketbeat.com

Pulse Biosciences consensus price target increased 12.27% to $51.82

September 16, 2026 | msn.com

Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules

September 15, 2026 | finance.yahoo.com

Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules

September 15, 2026 | businesswire.com

Pulse Biosciences (NASDAQ:PLSE) Upgraded by Freedom Capmkts to Strong-Buy Rating

September 11, 2026 | marketbeat.com

Pulse Biosciences, Inc (NASDAQ:PLSE) Receives Consensus Rating of "Moderate Buy" from Brokerages

September 11, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Reaches New 12-Month High - Should You Buy?

September 10, 2026 | marketbeat.com

Bank of New York Mellon Corp Invests $1.20 Million in Pulse Biosciences, Inc $PLSE

September 10, 2026 | marketbeat.com

Freedom Capital Markets initiates coverage of Pulse Biosciences with a buy rating

September 9, 2026 | msn.com

Why Pulse Biosciences Stock Popped Today

September 9, 2026 | fool.com

Pulse Biosciences (NASDAQ:PLSE) Trading Up 5.3% - Here's Why

September 9, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AORT, ITGR, LIVN, and PLSE Company Descriptions

Artivion NYSE:AORT

$22.25 -0.06 (-0.27%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$22.55 +0.30 (+1.37%)

As of 07:09 AM Eastern

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Integer NYSE:ITGR

$126.47 +0.02 (+0.01%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$126.44 -0.03 (-0.02%)

As of 10/2/2026 07:30 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova NASDAQ:LIVN

$75.07 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$75.03 -0.04 (-0.05%)

As of 10/2/2026 07:30 PM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Pulse Biosciences NASDAQ:PLSE

$47.90 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$47.88 -0.02 (-0.04%)

As of 07:30 AM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AORT, ITGR, LIVN, and PLSE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AORT, ITGR, LIVN, and PLSE Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AORT, ITGR, LIVN, and PLSE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AORT, ITGR, LIVN, and PLSE Company Descriptions

Artivion NYSE:AORT

Integer NYSE:ITGR

LivaNova NASDAQ:LIVN

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AORT, ITGR, LIVN, and PLSE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AORT, ITGR, LIVN, and PLSE Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AORT, ITGR, LIVN, and PLSE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AORT, ITGR, LIVN, and PLSE Company Descriptions

Artivion NYSE:AORT

Integer NYSE:ITGR

LivaNova NASDAQ:LIVN

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools